Anteris Technologies enters amended master services agreement with Switchback Medical

Anteris Technologies Global Corp.

Agreement covers development, manufacturing, engineering, and testing services at set prices per unit.
Company grants Switchback limited, exclusive, revocable license to certain IP solely for manufacturing.
Term expires March 31, 2028, with automatic one-year renewals unless terminated 180 days prior.
Company retains all rights to testing results, reports, data, and developed IP.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.